SAFRAN (EPA:SAF) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Home
Companies
SAFRAN

REGULATED PRESS RELEASE

published on 10/07/2024 at 15:23, 1 month 13 days ago

Statement of transactions in own shares from September 30, 2024 to October 04, 2024
REGULATED PRESS RELEASE

published on 09/30/2024 at 12:05, 1 month 21 days ago

Statement of transactions in own shares from September 23, 2024 to September 27, 2024
BRIEF

published on 09/20/2024 at 17:50, 2 months ago

Safran Announces Second Tranche of Share Buyback for Cancellation

Safran Share Buyback Investment CAC 40 Euro Stoxx 50
REGULATED PRESS RELEASE

published on 09/20/2024 at 17:45, 2 months ago

Safran - Share buyback for cancellation
Safran announces 500 million Euros share buyback for cancellation. Agreement with investment services provider. Operation in line with shareholder approval

Safran Shareholders Share Buyback Cancellation Investment Services
BRIEF

published on 09/09/2024 at 10:34, 2 months 12 days ago

SAFRAN Releases Update on Share Capital and Voting Rights

Safran Share Capital Voting Rights Financial Update August 2024
REGULATED PRESS RELEASE

published on 09/09/2024 at 10:29, 2 months 12 days ago

Statement about the number of shares composing the share capital and the number of voting rights as at August 31, 2024
Safran releases monthly statement on total number of shares and voting rights in compliance with French commercial code and AMF regulations

Safran Share Capital Voting Rights French Commercial Code Monthly Statement
REGULATED PRESS RELEASE

published on 08/09/2024 at 16:26, 3 months 11 days ago

Statement of transactions in own shares from August 05, 2024 to August 08, 2024
BRIEF

published on 08/09/2024 at 16:08, 3 months 11 days ago

Safran Releases Updated Share Capital and Voting Rights Information

Safran Share Capital Voting Rights Financial Markets Authority July 31, 2024
REGULATED PRESS RELEASE

published on 08/09/2024 at 16:03, 3 months 11 days ago

Statement about the number of shares composing the share capital and the number of voting rights as at July 31, 2024
Safran releases monthly statement on total number of shares and voting rights as per French commercial code and AMF regulations

Safran Share Capital Voting Rights French Commercial Code Monthly Statement
REGULATED PRESS RELEASE

published on 08/05/2024 at 15:13, 3 months 15 days ago

Statement of transactions in own shares from August 01, 2024 to August 02, 2024

Accesswire

Published on 11/21/2024 at 13:30, 19 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 19 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 49 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 49 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 49 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 34 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 13 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 34 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 42 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 49 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 29 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE